Equities

PolyPid Ltd

PYPD:NAQ

PolyPid Ltd

Actions
  • Price (USD)3.54
  • Today's Change-0.045 / -1.25%
  • Shares traded3.01k
  • 1 Year change-7.08%
  • Beta1.3059
Data delayed at least 15 minutes, as of Oct 07 2024 20:23 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

  • Revenue in USD (TTM)0.00
  • Net income in USD-24.70m
  • Incorporated2008
  • Employees59.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nexgel Inc5.01m-3.39m16.92m19.00--3.79--3.38-0.5722-0.57220.84640.65890.49423.036.44263,631.60-35.74-44.61-48.15-56.1923.745.02-72.33-180.980.8135--0.1992--99.6613.0633.48------
Cumberland Pharmaceuticals, Inc.37.79m-10.38m17.76m91.00--0.6735--0.47-0.7328-0.73282.671.870.45010.86433.17415,225.80-12.35-7.03-17.75-9.5282.5879.95-27.45-17.641.26-38.850.382---5.856.15-12.73---36.17--
TherapeuticsMD Inc996.00k-4.83m19.14m1.00--0.6918--19.22-0.4348-0.55380.08892.400.0212--0.5048996,000.00-10.31-53.35-13.13-111.6145.0886.67-485.34-236.57----0.00---98.14-39.53-816.85------
Tonix Pharmaceuticals Holding Corp12.46m-149.01m20.14m103.00--0.0336--1.62-110.99-110.996.164.280.10830.8436--120,951.50-129.55-59.46-157.22-65.9221.59---1,196.12-5,126.730.7181--0.1678------0.1874--320.57--
China Health Industries Holdings, Inc.95.95k-1.36m21.30m32.00------221.99-0.0208-0.02080.0015-0.03660.00370.503520.572,998.44-5.183.04-6.893.66-5.3469.55-1,419.4928.610.0377--1.76--41,225.93-55.72-15.49------
Cyclo Therapeutics Inc1.13m-20.74m21.52m8.00------19.00-0.9104-0.91040.0474-0.17850.2420.400213.16141,553.80-443.08-132.22---215.1791.5690.37-1,831.29-1,114.040.4283-------21.761.25-29.81---3.95--
BioXcel Therapeutics Inc2.40m-107.83m22.41m74.00------9.33-3.56-3.560.074-1.840.02340.59413.8732,472.97-104.93-74.57-150.29-84.0643.07---4,487.39-32,300.742.25-10.103.59--268.00---8.02---43.26--
DH Enchantment Inc100.00-173.19k22.99m1.00------229,878.60-0.0002-0.00020.00-0.00120.04380.1493--100.00-7,579.43------0.00---173,190.00--0.0029-14.85-----95.43--59.53------
KALA BIO Inc0.00-38.72m24.65m43.00--1.79-----13.95-13.950.002.980.00----0.00-60.45-57.83-78.16-69.32--57.06---1,553.61---11.360.7174---100.00--5.85---17.31--
Polypid Ltd0.00-24.70m24.90m59.00--10.61-----9.65-9.650.000.33370.00----0.00-107.89-76.92-164.39-89.61-----------24.210.8425------39.67---42.34--
Incannex Healthcare Inc12.00k-18.46m27.88m9.00--2.24--2,322.97-1.14-1.140.00070.70670.0003--0.00241,333.33-48.51-130.12-54.36-148.24-----153,833.30-3,421.98----0.00----61.0362.18--73.79--
Dare Bioscience Inc2.84m-7.20m28.20m23.00--10.56--9.93-1.07-1.070.35790.31260.1213--3.85123,462.20-30.76-109.51-191.39-246.260.8477---253.60-1,104.55----0.00---71.92--2.54--121.37--
Natural Alternatives International, Inc.113.80m-7.22m28.33m296.00--0.3431--0.2489-1.23-1.2319.3813.320.76763.969.52384,445.90-4.872.33-5.612.806.0314.24-6.342.061.59-10.210.13260.00-26.11-3.82-386.16---10.75--
Acasti Pharma Inc0.00-11.45m31.53m32.00--0.5312-----1.22-1.220.005.850.00-------16.04-31.68-16.57-33.95-------56,271.43---37.800.00------69.71---47.16--
Equillium Inc42.62m-8.32m33.09m45.00--1.47--0.7763-0.2377-0.23771.200.63330.8388--8.85968,704.60-16.37-46.81-29.58-57.36-----19.52-328.35----0.00--128.97--78.64--7.48--
Ocuphire Pharma Inc16.45m-14.11m33.27m14.00--0.8119--2.02-0.5507-0.55070.68711.560.3726--6.531,174,929.00-31.95-58.31-36.01-65.94-----85.75-137.92---10.800.00---52.20---155.83------
Data as of Oct 07 2024. Currency figures normalised to PolyPid Ltd's reporting currency: US Dollar USD

Institutional shareholders

22.96%Per cent of shares held by top holders
HolderShares% Held
AIGH Capital Management LLCas of 30 Jun 2024479.25k9.99%
Rosalind Advisors, Inc.as of 30 Jun 2024416.80k8.69%
DAFNA Capital Management LLCas of 31 Mar 2024185.45k3.87%
Yelin Lapidot Mutual Fund Management Ltd.as of 30 Jun 202411.15k0.23%
Steward Partners Investment Advisory LLCas of 30 Jun 20247.35k0.15%
Morgan Stanley & Co. LLCas of 31 Mar 2024732.000.02%
Securities America Advisors, Inc.as of 31 Mar 2024467.000.01%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024146.000.00%
BG Fund Management Luxembourg SAas of 31 Dec 2023104.000.00%
UBS Securities LLCas of 31 Mar 202419.000.00%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.